NCT00895167已完成1 期
The Effects of Oral Curcumin on Heme Oxygenase-1 (HO-1) in Healthy Male Subjects
Daniel Doberer2 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2009年1月最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 12
- 试验地点
- 2
- 主要终点
- The maximal HO-1 mRNA expression and HO-1 protein level in PBMCs
研究概览
简要总结
Heme oxygenase 1 (HO-1) serves as a protective gene. Induction of HO-1 has therapeutic potential for several indications. The inducibility of HO-1 by curcumin will be evaluated in this pilot study. Furthermore, the influence of a modulating factor of HO-1 gene activity on the dinucleotide guanosine thymine repeat (GT) length polymorphism in the promotor region will be investigated.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 45 Years（Adult）
- 性别
- Male
- 接受健康志愿者
- 是
入选标准
- •Signed informed consent prior to any study-mandated procedure.
- •Male patient aged between 18 and 45 years (inclusive) at screening.
- •No clinically significant findings on the physical examination at screening.
- •Body mass index (BMI) between 18 and 28 kg/m2 (inclusive) at screening.
- •12-lead ECG without clinically relevant abnormalities at screening.
- •Hematology, clinical chemistry, and urinalysis test results not deviating from the normal range to a clinically relevant extent at screening.
- •Negative results from urine drug screen at screening.
- •Ability to communicate well with the investigator, in the local language, and to understand and comply with the requirements of the study.
排除标准
- •Known hypersensitivity to the study drug or any excipients of the drug formulation.
- •Treatment with another investigational drug within 3 weeks prior to screening.
- •History or clinical evidence of alcoholism or drug abuse within the 3-year period prior to screening.
- •History or clinical evidence of any disease and/or existence of any surgical or medical condition, which might interfere with the absorption, distribution, metabolism or excretion of the study drugs.
- •Smoking within the last 3 months prior to screening.
- •Previous treatment with any prescribed or OTC medications (including herbal medicines such as St John's Wort) within 2 weeks prior to screening.
- •Regularly intake of curcumin rich food
- •Loss of 250 ml or more of blood within 3 months prior to screening.
- •Positive results from the hepatitis serology, except for vaccinated subjects, at screening.
- •Positive results from the HIV serology at screening.
- •Presumed non-compliance.
- •Legal incapacity or limited legal capacity at screening.
结局指标
主要结局
The maximal HO-1 mRNA expression and HO-1 protein level in PBMCs
时间窗: 48 hrs
次要结局
- Increase of plasma bilirubin level(48 hrs)
研究者
Daniel Doberer
Subinvestigator
Medical University of Vienna
研究点 (2)
Loading locations...
相似试验
已完成
1 期
Effects of Heme Arginate in Healthy Male SubjectsHealthy SubjectsHeme OxygenaseGenetic PolymorphismNCT00682370Daniel Doberer15
已完成
不适用
Reresveratrol Administered to Healthy Male SubjectsHealthy SubjectsHeme OxygenaseNCT01768507Daniel Doberer10
进行中（未招募）
1 期
Induction of Heme Oxygenase-1: a therapeutic approach to reduce hepatic ischaemia-reperfusion injury in liver surgery - HOLS studyEUCTR2008-005955-40-GBniversity of Edinburgh42
已完成
不适用
Heme Oxygenase-1 in Liver Surgeryiver surgery/pharmacological preconditioningSurgeryLiver surgeryISRCTN94278797niversity of Edinburgh (UK)42
已完成
1 期
Hemin in Healthy SubjectsHealthy VolunteersNCT00882804Mayo Clinic10